MedPath

Pharmacological Treatment of Depression.

Completed
Conditions
This is a double blind, randomized study with a washout period, comparing 2 treatments strategies.Study duration is 1 week washout period, 7 weeks acute treatment and continuation treatment of responders during 4 months.<br />One condition is with imipramine with adequate plasma levels the other is venlafaxine with optimal dosage
Registration Number
NL-OMON22391
Lead Sponsor
Erasmus MC
Brief Summary

/A

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
138
Inclusion Criteria

For inclusion in the trial, patients must fulfill all of the following criteria:

1. Age 18-65;

Exclusion Criteria

Any of the following is regarded as a criterion for exclusion from the trial:

1. Patients whom are incapable to understand the information and to give informed consent. And patients whom are unable to read or write;

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Change in HRSD scores.
Secondary Outcome Measures
NameTimeMethod
1. Change in CGI scores;<br /><br>2. Response defined as > 50% reduction on HRSD compared to baseline;<br /><br>3. Remission defined as an end score of < 7 on the HRSD.
© Copyright 2025. All Rights Reserved by MedPath